FDA issued a Warning Letter to Sovereign Pharmaceuticals, LLC on 01/29/2013 for a previous inspection.
483 Sovereign Pharmaceuticals Nov 2016

483 Sovereign Pharmaceuticals Nov 2016

Scott Ballard FDA$119.00 - Available Now

FDA investigators audited the Sovereign Pharmaceuticals - Fort Worth, TX, United States facility and issued 4 inspectional observations (via FDA 483) on 10 Nov 2016.

Product details

  • Category: Human Drugs
  • Number of Observations: 4
  • Inspection end: 10 Nov 2016
  • Location: Fort Worth, United States
  • FEI: 3003229412
Add To Cart